
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company engaged in the R&D of tissue-engineered and cell therapy products. Bonus CEO Dr. Shai Meretzki, one of Israels most prominent biotech entrepreneurs, founded Bonus to build live tissues outside the body. He started with bones, developing BonoFill, the worlds first tissue-engineered viable bone graft for treating severe bone defects currently under-treated by transplanting bone from another part of the body with considerable limitations. The active ingredients in BonoFill are mesenchymal cells isolated from the patients adipose tissue. Using BonoFill, bones were successfully regenerated in already dozens of patients that recovered...
Bone tissue engineering,biotechnology,adipose-derived stem cells,mesenchymal stem cells,critical gap bone fractures,maxillofacial tissue engineering,biomedical engineering,orthopedics,and innovation
Bonus biogroup operates in the Biotechnology research industry.
Bonus biogroup's revenue is 11m - 100m
Bonus biogroup has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.